These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3120632)

  • 1. Pulmonary penetration of alpha 1-proteinase inhibitor administered parenterally to dogs.
    Smith RM; Spragg RG; Moser KM; Cochrane CG; McCarren JP
    Am Rev Respir Dis; 1987 Dec; 136(6):1391-6. PubMed ID: 3120632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and administration to dogs of aerosols of alpha-1-proteinase inhibitor.
    Smith RM; Spragg RG
    Am J Med; 1988 Jun; 84(6A):48-51. PubMed ID: 3260073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous administration of alpha-1-proteinase inhibitor in patients of PiZ and PiM phenotype. Preliminary report.
    Moser KM; Smith RM; Spragg RG; Tisi GM
    Am J Med; 1988 Jun; 84(6A):70-4. PubMed ID: 3260074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep.
    Smith RM; Traber LD; Traber DL; Spragg RG
    J Clin Invest; 1989 Oct; 84(4):1145-54. PubMed ID: 2794051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local increase of antiprotease and neutrophil elastase-alpha 1-proteinase inhibitor complexes in lung cancer.
    Marchandise FX; Mathieu B; Francis C; Sibille Y
    Eur Respir J; 1989 Jul; 2(7):623-9. PubMed ID: 2476329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proteinase-antiproteinase balance in alpha-1-proteinase inhibitor-deficient lung transplant recipients.
    King MB; Campbell EJ; Gray BH; Hertz MI
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):966-71. PubMed ID: 8143063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional activity of the alpha1-proteinase inhibitor in serum and bronchoalveolar lavage fluid in congenital lung emphysema].
    Trefz G; Heck B; Schulz V; Ebert W
    Pneumologie; 1989 Aug; 43(8):446-51. PubMed ID: 2788886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo quantitation of epithelial lining fluid in dog lung.
    Bayat S; Menaouar A; Anglade D; Ettinger H; François-Joubert A; Benchetrit G; Grimbert FA
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1715-23. PubMed ID: 9847258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of lung antineutrophil elastase capacity with recombinant human alpha-1-antitrypsin.
    Casolaro MA; Fells G; Wewers M; Pierce JE; Ogushi F; Hubbard R; Sellers S; Forstrom J; Lyons D; Kawasaki G
    J Appl Physiol (1985); 1987 Nov; 63(5):2015-23. PubMed ID: 3500941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproteases are increased in bronchoalveolar lavage in interstitial lung disease.
    Sibille Y; Martinot JB; Staquet P; Delaunois L; Chatelain B; Delacroix DL
    Eur Respir J; 1988 Jun; 1(6):498-504. PubMed ID: 2458961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidant effects on rat and human lung proteinase inhibitors.
    Johnson DA; Winters RS; Lee KR; Smith CE
    Res Rep Health Eff Inst; 1990 Dec; (37):1-39. PubMed ID: 1706189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of alpha-1-proteinase inhibitor. Pharmacokinetics and safety studies.
    Fournel MA; Newgren JO; Betancourt CM; Irwin RG
    Am J Med; 1988 Jun; 84(6A):43-7. PubMed ID: 3260072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term substitution in homozygous alpha 1-antitrypsin deficiency. Effect of the proteinase-antiproteinase equilibrium in plasma and sputum].
    Braun J; Welle S; van Wees J; Winterhoff R; Wood WG; Dalhoff K; Wiessmann KJ
    Dtsch Med Wochenschr; 1990 Jun; 115(23):889-94. PubMed ID: 2191843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of alpha 1-proteinase inhibitor methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone and specific beta-lactam inhibitors in an acute model of human polymorphonuclear leukocyte elastase-induced lung hemorrhage in the hamster.
    Fletcher DS; Osinga DG; Hand KM; Dellea PS; Ashe BM; Mumford RA; Davies P; Hagmann W; Finke PE; Doherty JB
    Am Rev Respir Dis; 1990 Mar; 141(3):672-7. PubMed ID: 2310097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elastase inhibitors of the respiratory tract.
    Stockley RA; Morrison HM
    Eur Respir J Suppl; 1990 Mar; 9():9s-15s. PubMed ID: 2340054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and distribution of recombinant secretory leukocyte proteinase inhibitor in rats.
    Gast A; Anderson W; Probst A; Nick H; Thompson RC; Eisenberg SP; Schnebli H
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):889-94. PubMed ID: 2327652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of sheep alpha-1-proteinase inhibitor. Important differences from the human protein.
    Sinha U; Sinha S; Janoff A
    Am Rev Respir Dis; 1988 Mar; 137(3):558-63. PubMed ID: 3257851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratracheally-instilled antileukoprotease and alpha 1-proteinase inhibitor: effect on human neutrophil elastase-induced experimental emphysema and pulmonary localization.
    Rudolphus A; Kramps JA; Mauve I; Dijkman JH
    Histochem J; 1994 Oct; 26(10):817-24. PubMed ID: 7883591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic availability of injected or aerosolized alpha 1 proteinase inhibitor.
    Smith RM; Spragg RG; Moser KM
    Prog Clin Biol Res; 1987; 236A():203-10. PubMed ID: 3497405
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the turnover of methionine oxidized alpha-1-protease inhibitor in rats.
    Glaser CB; Karic L; Parmelee S; Premachandra BR; Hinkston D; Abrams WR
    Am Rev Respir Dis; 1987 Oct; 136(4):857-61. PubMed ID: 3499103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.